Cartesian Therapeutics
Cartesian Therapeutics is a clinical-stage biotechnology company focused on developing innovative cell therapies for autoimmune diseases and other serious conditions. Leveraging proprietary RNA cell therapy platforms, Cartesian Therapeutics aims to deliver targeted, scalable, and durable treatments that address significant unmet medical needs. The company’s pipeline includes multiple investigational therapies designed to modulate immune responses with precision and safety. By integrating advanced RNA engineering with cell therapy, Cartesian Therapeutics is committed to advancing the field of immunotherapy and improving patient outcomes. The company collaborates with leading research institutions to accelerate the development and commercialization of its novel therapeutic candidates.
